Resource Central is a product of the Pediatric Pandemic Network.

Nirsevimab Library

This is a collection of current resources related to Nirsevimab.

Notes from the Field: Rollout of Nirsevimab to Protect Infants and Young Children During the Respiratory Syncytial Virus Season — New York City, 2023–2024
2024 · New York City Department of Health and Mental Hygiene, · Centers for Disease Control and Prevention (CDC)
This analysis reviewed nirsevimab dosing based on Vaccines for Children (VFC) eligibility in New York City during the 2023–24 RSV season. A nirsevimab shortage in …
Nirsevimab Clinical Guidance and VFC Ordering [Letter]
2024 · New York City Department of Health and Mental Hygiene
This letter provides clinical guidance on the use of nirsevimab (Beyfortus), a monoclonal antibody that protects infants and toddlers from respiratory syncytial virus (RSV). Information …

Looking for different way to find resources?

Our chatbot aRCie can help with a more personalized search. Click below to try our new chatbot.

Try aRCie